rs281860301
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_005247.4(FGF3):c.150C>T(p.Cys50Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FGF3
NM_005247.4 synonymous
NM_005247.4 synonymous
Scores
1
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.47
Publications
3 publications found
Genes affected
FGF3 (HGNC:3681): (fibroblast growth factor 3) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene was identified by its similarity with mouse fgf3/int-2, a proto-oncogene activated in virally induced mammary tumors in the mouse. Frequent amplification of this gene has been found in human tumors, which may be important for neoplastic transformation and tumor progression. Studies of the similar genes in mouse and chicken suggested the role in inner ear formation. [provided by RefSeq, Jul 2008]
FGF3 Gene-Disease associations (from GenCC):
- deafness with labyrinthine aplasia, microtia, and microdontiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP7
Synonymous conserved (PhyloP=2.47 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGF3 | NM_005247.4 | c.150C>T | p.Cys50Cys | synonymous_variant | Exon 1 of 3 | ENST00000334134.4 | NP_005238.1 | |
| LOC107984368 | XR_001748071.2 | n.77G>A | non_coding_transcript_exon_variant | Exon 1 of 3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00000991 AC: 1AN: 100878 AF XY: 0.0000177 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
100878
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1343574Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 663178
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1343574
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
663178
African (AFR)
AF:
AC:
0
AN:
27342
American (AMR)
AF:
AC:
0
AN:
30716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23702
East Asian (EAS)
AF:
AC:
0
AN:
30806
South Asian (SAS)
AF:
AC:
0
AN:
75236
European-Finnish (FIN)
AF:
AC:
0
AN:
34196
Middle Eastern (MID)
AF:
AC:
0
AN:
4434
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1061386
Other (OTH)
AF:
AC:
0
AN:
55756
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.